 |
|
Study finds a high caloric diet may prevent the progression of amyotrophic lateral sclerosis
April 18, 2006Mount Sinai School of Medicine researchers publish first study showing link between diet and ALS
New York, New York --A recent study directed by the Mount Sinai School of Medicine suggests a ketogenic- high caloric diet may prevent the progression of Amyotrophic Lateral Sclerosis (ALS). This study, which appears in the April 3, 2006 issue of BMC Neuroscience, is the first to draw a correlation between diet and neuronal cell death, the cause of ALS.
ALS is an adult-onset neurodegenerative disorder in which spinal and cortical motor neurons die causing relentlessly progressive weakness and wasting of skeletal muscles through the body.
"ALS is such a devastating disease for those individuals diagnosed with the disorder," said Giulio Maria Pasinetti, M.D., Ph.D., Professor of Psychiatry and Neuroscience, Director of the Neuroinflammation Research Center at The Mount Sinai School of Medicine and lead author of this study. "The findings assert the significance of certain high caloric dietary intake in the prevention of ALS. In view of any available therapeutic application for the disease, this new evidence might bring hope to those affected."
The cause of neuronal death in ALS is uncertain but study researchers say mitochondrial dysfunction plays an important role. Ketones promote mitochondrial energy production and membrane stabilization. Mitochondiral membrane dysfunction, loss of oxidative stress control, generation of excessive free radicals, neurofilament accumulation, and excitotoxicity are all implicated in the onset of ALS.
About the Study
Mount Sinai School of Medicine investigators used a mouse model to examine the affects of a ketogenic diet (KD) on the progression of ALS. ALS mice were fed a high caloric - ketogenic diet (KD) and motor performance, longevity, and motor neuron counts were measured in treated and diseased mice. Because mitochondrial dysfunction plays a central role in neuronal cell death in ALS, the effect that the principal ketone body, D-â-3 hydroxybutyrate (DBH), has on mitochondrial ATP generation and neuroprotection were studied.
Blood ketones were > 3.5 times higher in KD fed animals compared to controls. KD fed mice lost 50% of baseline motor performance 25 days later than the disease controls. The interaction between diet and change in weight was significant; KD mice weighed 4.6g more than the disease control group at study endpoint. In spinal cord sections obtained at the study endpoint, there were more motor neurons in KD fed animals. DBH prevented rotenone mediated inhibition of mitochondrial complex I but not malonate inhibition of complex II. Rotenone neurotoxicity in spinal cord motorneuron was also inhibited by DBH.
The Conclusions
This is the first study showing that diet, specifically a high caloric-KD, may slow the progression of the clinical and biological manifestations of ALS in a mouse model. This may be due to the ability of ketone bodies to promote ATP synthesis and bypass inhibition of complex I in the mitochondrial respiratory chain.
The Mount Sinai Hospital / Mount Sinai School of Medicine
"ALS is such a devastating disease for those individuals diagnosed with the disorder," said Giulio Maria Pasinetti, M.D., Ph.D., Professor of Psychiatry and Neuroscience, Director of the Neuroinflammation Research Center at The Mount Sinai School of Medicine and lead author of this study. "The findings assert the significance of certain high caloric dietary intake in the prevention of ALS. In view of any available therapeutic application for the disease, this new evidence might bring hope to those affected."
The cause of neuronal death in ALS is uncertain but study researchers say mitochondrial dysfunction plays an important role. Ketones promote mitochondrial energy production and membrane stabilization. Mitochondiral membrane dysfunction, loss of oxidative stress control, generation of excessive free radicals, neurofilament accumulation, and excitotoxicity are all implicated in the onset of ALS.
About the Study
Mount Sinai School of Medicine investigators used a mouse model to examine the affects of a ketogenic diet (KD) on the progression of ALS. ALS mice were fed a high caloric - ketogenic diet (KD) and motor performance, longevity, and motor neuron counts were measured in treated and diseased mice. Because mitochondrial dysfunction plays a central role in neuronal cell death in ALS, the effect that the principal ketone body, D-â-3 hydroxybutyrate (DBH), has on mitochondrial ATP generation and neuroprotection were studied.
Blood ketones were > 3.5 times higher in KD fed animals compared to controls. KD fed mice lost 50% of baseline motor performance 25 days later than the disease controls. The interaction between diet and change in weight was significant; KD mice weighed 4.6g more than the disease control group at study endpoint. In spinal cord sections obtained at the study endpoint, there were more motor neurons in KD fed animals. DBH prevented rotenone mediated inhibition of mitochondrial complex I but not malonate inhibition of complex II. Rotenone neurotoxicity in spinal cord motorneuron was also inhibited by DBH.
The Conclusions
This is the first study showing that diet, specifically a high caloric-KD, may slow the progression of the clinical and biological manifestations of ALS in a mouse model. This may be due to the ability of ketone bodies to promote ATP synthesis and bypass inhibition of complex I in the mitochondrial respiratory chain.
The Mount Sinai Hospital / Mount Sinai School of Medicine
Amyotrophic Lateral Sclerosis Current Events and Amyotrophic Lateral Sclerosis News RSSSchizophrenia gene's role may be broader, more potent, than thought
UCSF scientists studying nerve cells in fruit flies have uncovered a new function for a gene whose human equivalent may play a critical role in schizophrenia.
Compound shows potential for slowing progression of ALS
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice.
New guidelines identify best treatments to help ALS patients live longer, easier
New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The guidelines are published in the October 13, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.
Scientists encouraged by new mouse model's similarities to human ALS
A new mouse model of amyotrophic lateral sclerosis (ALS) closely resembles humans with the paralyzing disorder, researchers at Washington University School of Medicine in St. Louis report.
Amyotrophic lateral sclerosis may involve a form of sudden, rapid aging of the immune system
Premature aging of the immune system appears to play a role in the development of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to research scientists from the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, the Weizmann Institute of Science in Israel, and Sheba Medical Center in Israel.
Physician-assisted suicide does not increase severity of depression, grief among family members
Unlike other forms of suicide, physician assisted death does not cause substantial regret, or a sense of rejection among surviving family members.
Mechanism related to the onset of various genetic diseases revealed
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.
Michigan Tech Mathematicians Identify Genes Linked to Lou Gehrig's Disease
Michigan Technological University researchers have linked three genes to the most common type of amyotrophic lateral sclerosis (ALS), generally known as Lou Gehrig's disease.
New Jefferson study may redefine how a chronic auto-immune disease is diagnosed
New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed.
Fatal brain disease at work well before symptoms appear
University of Florida scientists have discovered why a paralyzing brain disorder speeds along more rapidly in some patients than others - a finding that may finally give researchers an entry point toward an effective treatment for amyotrophic lateral sclerosis, often referred to as ALS or Lou Gehrig's disease.
More Amyotrophic Lateral Sclerosis Current Events and Amyotrophic Lateral Sclerosis News Articles
 |
Amyotrophic Lateral Sclerosis: A Guide for Patients and Families by M.D. Hiroshi Mitsumoto (Editor) This important book covers every aspect of living with ALS, from clinical features of the disease to an overview of symptom management to understanding its diagnosis. Major sections deal with overseeing medical care and rehabilitation, living with ALS, the disease’s advanced phase, end-of-life issues, and resources. Extensively revised and rewritten, this edition contains new chapters on the latest approaches to treating ALS symptoms, the use of noninvasive ventilators, multidisciplinary team care, new guidelines being developed by the American Academy of Neurology for patients with ALS, the use of riluzole (Rilutek), and more. |
 |
Amyotrophic Lateral Sclerosis (American Academy of Neurology) by M.D. Robert G. Miller (Author), M.D. Deborah Gelinas (Author), RN Patricia O'Connor (Author) ALS, also known as Lou Gehrig's disease, cannot be cured, but treatments are now available that can make a major difference in prolonging and enhancing life. Written by clinicians who manage one of the leading ALS centers in the world, this book guides readers through an understanding what ALS is, how it is diagnosed, the management of symptoms, and the drugs that are available to treat the underlying disease process. Chapters cover topics that include nutrition and swallowing; speech, communication, and computer access; mobility; breathing and sleeping; end-of-life care; and much more, including insurance issues and practical tips. Chapters from leading ALS organizations offer a broad list of support services, publications, websites, and other resources. |
 |
Amyotrophic Lateral Sclerosis Awareness Ribbon Mouse Pad by MyHeritageWear.com The Amyotrophic Lateral Sclerosis proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Amyotrophic Lateral Sclerosis than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Amyotrophic Lateral Sclerosis mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
|
Ecological Formulas Sphingolin Caps 60's (Use of This Product May Benefit Those with Myelin Diseases Such As Multiple Sclerosis (Ms) and Amyotrophic Lateral Sclerosis (Als -Lou Gehrig's Disease) by Ecological Formulas This product, from Ecological Formulas, is an extract of bovine myelin sheath and is a rich source of myelin protective proteins. Use of this product may benefit those with myelin diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS -Lou Gehrig's Disease) | |
 |
The Man Who Learned to Fall Directed By: Garry Beitel Also With: Garry Beitel and Barry Lazar (Producer) The Man Who Learned to Fall is a feature documentary about a gifted writer and sought after teacher who celebrates the wonder of life even as he is slowly dying of a fatal neuromuscular condition. At the age of 35, Philip Simmons learned that he had ALS or Lou Gehrigs disease. Married, with two young children and a promising career as an English Professor and writer, he was told that he had less than five years to live. Filmed in the foothills of the White Mountains of New Hampshire, this intimate portrait of Phil and his family captures the witty eloquence and poetic grace of a dying man and his heroic journey. As his muscles deteriorate and his body becomes increasingly paralyzed, Philip Simmons continues to wrestle joy from heartbreak, again and again and again, at each stage of his... |
 |
Body & Soul Also With: Warner Bros. (Producer) |
 |
ALS Awareness Key Chain, Oregon & SW Washington Chapter by Abernook Show support and spread ALS awareness with the swarovski crystal and bali silver keychain. This bracelet is designed using Swarovski crystals and Bali silver. Spouses, family and friends can now show their support and spread knowledge and awareness about the disease. A portion of the proceeds is being given to the ALS Association. Also available, ALS Bracelet, Earrings and Purse Charm |
 |
ALS Awareness Loop, ALSA New Mexico Chapter by Abernook This mini bracelet was designed to adorn wheelchairs, rear view mirrors, back packs and purses (as a purse charm). Now you can show your support any time. Made with Swarovski Crystals, Bali Silver along with a silver awareness charm. A portion of the proceeds is being donated to the ALS Chapters. |
 |
ALS Awareness Earrings, Oregon & SW Washington Chapter by Abernook Made with Swarovski Crystals and Bali Silver, you can now show your support through these ALS earrings. A portion of the proceeds goes to the ALS Association to provide aid in research, patient care, family care and support. Also available ALS bracelet and Purse Charm |
 |
Amyotrophic Lateral Sclerosis, Second Edition by Robert H. Brown Jr. (Editor), Michael Swash (Editor), Piera Pasinelli (Editor) Amyotrophic lateral sclerosis or motor neurone disease is one of the most debilitating and devastating of the neurological diseases. The only comprehensive textbook available on the topic, this completely reorganized and expanded new edition examines all aspects of ALS from pathology to patient care and provides the reader with a ready reference to help with the difficulties encountered in patient diagnosis and treatment. Undoubtedly an important work in the field, this book will be of great interest to clinical neurologists and trainees, and to all those concerned with the care of people with ALS. |
| © 2009 BrightSurf.com |